Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

NCT07193147 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: GZR4

Sponsor

Gan & Lee Pharmaceuticals.